Morgan Stanley’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
|
|||||
|
2025
Q1 | $2.68M | Sell |
|
|||||
|
2024
Q4 | $7.02M | Buy |
|
|||||
|
2024
Q3 | $11.4M | Sell |
|
|||||
|
2024
Q2 | $18.9M | Sell |
|
|||||
|
2024
Q1 | $35.7M | Sell |
|
|||||
|
2023
Q4 | $22.1M | Buy |
|
|||||
|
2023
Q3 | $6.31M | Buy |
|
|||||
|
2023
Q2 | $6.58M | Buy |
|
|||||
|
2023
Q1 | $5.34M | Sell |
|
|||||
|
2022
Q4 | $6.44M | Sell |
|
|||||
|
2022
Q3 | $9.42M | Sell |
|
|||||
|
2022
Q2 | $11.6M | Buy |
|
|||||
|
2022
Q1 | $11.9M | Buy |
|
|||||
|
2021
Q4 | $9.43M | Sell |
|
|||||
|
2021
Q3 | $9.22M | Sell |
|
|||||
|
2021
Q2 | $7.76M | Buy |
|
|||||
|
2021
Q1 | $7.19M | Sell |
|
|||||
|
2020
Q4 | $6.66M | Buy |
|
|||||
|
2020
Q3 | $4.13M | Buy |
|
|||||
|
2020
Q2 | $3.13M | Sell |
|
|||||
|
2020
Q1 | $3.51M | Sell |
|
|||||
|
2019
Q4 | $14.6M | Buy |
|
|||||
|
2019
Q3 | $9.99M | Buy |
|
|||||
|
2019
Q2 | $9.19M | Buy |
|
|||||
|
2019
Q1 | $7.42M | Sell |
|
|||||
|
2018
Q4 | $13.6M | Buy |
|
|||||
|
2018
Q3 | $3.41M | Sell |
|
|||||
|
2018
Q2 | $6M | Sell |
|
|||||
|
2018
Q1 | $4.66M | Buy |
|
|||||
|
2017
Q4 | $2.75M | Buy |
|
|||||
|
2017
Q3 | $1.59M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Sell |
|
|||||
|
2017
Q1 | $1.18M | Sell |
|
|||||
|
2016
Q4 | $1.68M | Buy |
|
|||||
|
2016
Q3 | $140K | Sell |
|
|||||
|
2016
Q2 | $196K | Buy |
|
|||||
|
2016
Q1 | $202K | Sell |
|
|||||
|
2015
Q4 | $356K | Buy |
|
|||||
|
2015
Q3 | $148K | Sell |
|
|||||
|
2015
Q2 | $226K | Sell |
|
|||||
|
2015
Q1 | $266K | Sell |
|
|||||
|
2014
Q4 | $584K | Buy |
|
|||||
|
2014
Q3 | $179K | Sell |
|
|||||
|
2014
Q2 | $208K | Sell |
|
|||||
|
2014
Q1 | $208K | Sell |
|
|||||
|
2013
Q4 | $170K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $773K | Buy |
|